Home / Health / Fake Obesity Drugs Harm Health in 11 Countries
Fake Obesity Drugs Harm Health in 11 Countries
17 Mar
Summary
- Counterfeit drugs found in 11 countries contain harmful substances.
- Global shortages and high costs drive patients to risky online markets.
- Fake medications pose fatal risks due to contamination and dosage errors.
A sophisticated global network distributing counterfeit anti-obesity drugs has been uncovered, with illicit products detected in at least 11 countries. The Lancet's report reveals these dangerous fakes can contain harmful substances, including high-dose insulin, posing fatal risks to unsuspecting users. This crisis is fueled by significant global shortages of legitimate weight-loss medications and their high cost, pushing vulnerable individuals toward unregulated online pharmacies.
The counterfeit drugs are often sold through clandestine online shops, containing either no active ingredients or dangerous substitutes. Investigations have found formulations with harmful bacteria or dangerously inaccurate dosages, including one pen with five times the stated active ingredient. This situation creates a perfect storm of supply gaps, unaffordable legitimate treatments, and a digital landscape easily exploited by scammers.
Regulatory bodies face challenges in tracking these fragmented supply chains, particularly in regions with strained healthcare infrastructure. Experts stress the importance of purchasing medications only from licensed pharmacies, scrutinizing packaging for errors, and always consulting a doctor before starting any weight-loss treatment. Technology like blockchain is suggested, but international cooperation is vital to shut down illicit online storefronts and make legitimate treatments more accessible.
